ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Next issue of The Cancer Letter is scheduled for Jan. 7, 2005.

December 10, 2004

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

1981 Budget By Funding Mechanism

June 1, 1979

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

NCI CTEP-Approved Trials For the Month of March

March 28, 2014

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011